Castle Biosciences: Q4 Earnings Insights

Castle Biosciences CSTL reported its Q4 earnings results on Monday, February 28, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Castle Biosciences beat estimated earnings by 46.81%, reporting an EPS of $-0.25 versus an estimate of $-0.47.

Revenue was up $7.74 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.07 which was followed by a 10.19% drop in the share price the next day.

Here's a look at Castle Biosciences's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.40 -0.37 -0.24 -0.12
EPS Actual -0.47 -0.34 -0.17 -0.17
Revenue Estimate 22.97M 18.93M 16.66M 15.74M
Revenue Actual 23.48M 22.76M 22.81M 17.30M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
▲▼
ticker
▲▼
name
▲▼
Actual EPS
▲▼
EPS Surprise
▲▼
Actual Rev
▲▼
Rev Surprise
▲▼
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!